At Myriad, we recognize the critical role genetic counselors play in patient care, which is why the National Society of Genetic Counselors (NSGC) Conference is so significant. This event provides an unparalleled opportunity for collaboration, allowing us to engage directly with you—our valued partners.
By visiting booth #317, you can explore the latest research, innovations, and support services available from Myriad.
Myriad offers a portfolio of genetic and genomic tests that deliver personalized insights and help patients and healthcare providers detect health risks, tailor treatments, and prevent disease with precision.
Explore products in our cancer care continuum
Discover the latest enhancements in prenatal screening
Genetic specialists like you emotionally support and guide patients through some of life’s most important journeys—no matter how high your caseloads mount.
That’s why Myriad is grateful to have one of the largest teams of board-certified genetic counselors in the nation. You can customize their services to help extend your circle of care, with:
Discover all the ways we can help you meet the rapidly rising demand for your expert guidance.
Our comprehensive support services help reduce administrative burdens, increase confidence, and accelerate clinical action, at no extra cost for you and your patients.5
Genetic testing with Myriad provides you access to our board-certified genetic counselors for pre- and post-test patient support in 200+ languages, 5 days a week at no extra cost. We’re here to complement your practice workflow as you increase patient caseloads.
Remove barriers for your clinic by adapting our services to the ways you currently practice.
Customize our pre- and post-test education, personalized for each patient, in whatever ways you prefer, so you can keep giving everyone you counsel your very best care.
Leveraging a Longitudinal Genomics Platform to Recontact Patients Eligible for Hereditary Cancer Genetic Testing
Date: Saturday, November 8, 5:00PM
Product: MyRisk
Presenter: Kaylee Henson, MS, CGC
RNA Analysis from Residual Blood Aids the Interpretation of VUS Identified in Individuals Undergoing Hereditary Cancer Genetic Testing
Date: Friday, November 7, 5:15PM
Presenter: Paola Nix, Phd, HCLD (ABB)
Fetal Fraction Amplification Yields Sufficient Fetal Fraction to Enable cfDNA Screening with a Low Screen-Failure Rate Between 8-10 Weeks Gestation
Product: Prequel
Presenter: Ronit Lebor, MS, CGC
Provider & Patient Uptake of Prenatal cfDNA Screening at an Earlier Gestational Age
Presenter: Lauren Eisemann, MS, CGC
Prenatal Cell-Free DNA Screening Helps Uncover Maternal Colorectal Cancer: A Case Study
Presenter: Meghan Krieger, MS, CGC
High-Throughput, Automated Detection of FXN Repeat Expansions Using Repeat Primed PCR Followed by Capillary Electrophoresis
Product: Foresight
Presenter: Jhett Bordwell, MS, PhD
From Concept to Care: The Evolution of a Genetic Screening Report through Clinical and Design Collaboration
Product: FirstGene
Presenter: Summer Pierson, MS, CGC
The Spectrum of Germline Hereditary Cancer Mutations Within a Laboratory-Based Research Registry
Product: MCRR
Presenter: Damini Morah, MS, CGC
EXTERNALLY DRIVEN - Comparison of Cancer Types Associated with ATM and CHEK2 Within a Hospital System and National Registry
Date: TBD
Presenter: McCall Larson
Shaping the Future: Evolving a Field-Based Laboratory Rotation to Meet the Needs of Genetic Counseling Students
Presenter: Sarah Pass, MMSc, CGC
Genetic Counseling Student Interest in GC Roles in an Industry Rotation Setting
Presenter: Heather Bagley, MS, CGC
Professional Development for Seasoned Genetic Counselors: Moving from Clinical Expertise to Leadership Excellence
Presenter: Susan Manley, LCGC, MBA
Get customized patient education and seamless support from fellow genetic counselors, so you can help even more patients—all at no extra cost
Connect with us